| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE | 9 |
| 1 | METHOTREXATE SODIUM | 9 |
| 2 | VALGANCICLOVIR | 8 |
| 3 | VALGANCICLOVIR HYDROCHLORIDE | 8 |
| 4 | VALGANCICLOVIR HYDROCHLORIDE POWDER, | 8 |
| 5 | BENDAMUSTINE HCL | 7 |
| 6 | FLUOROURACIL | 7 |
| 7 | FLUOROURACIL CREAM, 0.5% | 7 |
| 8 | LEFLUNOMIDE | 7 |
| 9 | PREDNISONE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BREXUCABTAGENE AUTOLEUCEL | 3 | 0.0014 |
| 1 | INOTUZUMAB OZOGAMICIN | 3 | 0.0010 |
| 2 | PENTOSTATIN | 1 | 0.0010 |
| 3 | SUFENTANIL CITRATE | 1 | 0.0008 |
| 4 | APOMORPHINE HYDROCHLORIDE | 1 | 0.0006 |
| 5 | BENDAMUSTINE HCL | 7 | 0.0004 |
| 6 | VALGANCICLOVIR | 8 | 0.0004 |
| 7 | RASBURICASE | 1 | 0.0004 |
| 8 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 9 | PYRAZINAMIDE | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 3 | 0.0010 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 2 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 3 | Antimycobacterial [EPC] | 3 | 0.0001 |
| 4 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 5 | Antimalarial [EPC] | 1 | 0.0001 |
| 6 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 7 | Rifamycin Antibacterial [EPC] | 3 | 0.0001 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 5 | 0.0001 |
| 9 | Antirheumatic Agent [EPC] | 7 | 0.0001 |